MarketScreener

AbbVie Presents Data for ABBV-466, a Novel Dual-Targeting Therapy Demonstrating Higher Endoscopic Remission Rates Than Either Anti-IL-23 or Anti-α4β7 Monotherapy in Moderate ...

In a Phase 2a study, ABBV-466 achieved higher endoscopic remission rates in patients with Crohn's disease than either anti-IL-23 p19 or anti-α4β7 monotherapy at Week 12, the primary endpoint. The ...
en.sedaily

Only 22% of Prime Contractors Open Talks Under New Union Law

Only 102 of 456 Korean outsourcing employers entered talks under the revised union law, while youth employment fell again in ...
en.sedaily

Only 27% of Firms Say Labor Board Rulings Follow Law, KEF Finds

Only 27.4% of Korean firms say labor board rulings on prime contractors' employer status follow the law, a Korea Enterprises ...
markets.chroniclejournal

CC Class Action Notice: Chemours Sued for Securities Fraud After Opteon Demand Issues Lead to 18% Stock Drop – Investors Urged to Contact BFA Law by December 7 Deadline

Chemours offers a range of industrial and specialty chemical products, including Opteon, a set of refrigeration chemicals with a reduced ozone-depletion footprint. In late 2020, Congress enacted the U ...